Clene Inc.
NASDAQ:CLNNBiotechnology
Healthcare
$3.50 +1.35%
+$0.08 today
- Market cap
- $50.40M
- Beta
- 0.92
- P/E (TTM)
- -2.1
- EPS (TTM)
- -$2.88
52W Low $3.25High $13.50
Volume 0.12M
Average 0.50M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$18.55M
FY 2025 · Annual
Investing Cash Flow
-$39,000.00
FY 2025 · Annual
Financing Cash Flow
$11.52M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (9.74M) | (29.92M) | (49.5M) | (39.4M) | (26.17M) |
| Depreciation & Amortization | 955K | 1.02M | 1.71M | 1.65M | 1.5M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 12.38M | 8.51M | 9.12M | 7.95M | 6.38M |
| Change in Working Capital | 1M | (1.54M) | (191K) | 3.21M | (3.35M) |
| Accounts Receivables | (28K) | (140K) | 46K | 79K | 64K |
| Inventory | 150K | (2K) | 6K | (31K) | 31K |
| Accounts Payables | 1.27M | 285K | (1.51M) | (264K) | (348K) |
| Other Working Capital | (386K) | (1.68M) | 1.27M | 3.43M | (3.1M) |
| Other Non-Cash Items | (39.23M) | (17.09M) | 8.7M | 5.27M | 3.1M |
| Operating Cash Flow | (34.62M) | (39.01M) | (30.17M) | (21.33M) | (18.55M) |
| Capital Expenditures | (1.33M) | (5.18M) | (330K) | (15K) | (39K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | (24.61M) | (6.17M) | (6.17M) | 0 |
| Sales of Investments | 0 | 19.63M | 5M | 12.5M | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (1.33M) | (10.16M) | (1.5M) | 6.32M | (39K) |
| Debt Repayment | 19.84M | 5.56M | 269K | (10.9M) | 1.12M |
| Common Stock Issued | 9.25M | 11.46M | 42.09M | 9.24M | 10.4M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.98M) | 229K | (200K) | 124K | 0 |
| Financing Cash Flow | 27.11M | 17.25M | 42.16M | (1.53M) | 11.52M |
| Effect of Forex Changes | (85K) | (30K) | (4K) | (127K) | 101K |
| Net Change in Cash | (8.93M) | (31.96M) | 10.49M | (16.67M) | (6.97M) |
| Free Cash Flow | (35.96M) | (44.19M) | (30.5M) | (21.34M) | (18.59M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$26.2M
+ D&A$1.5M
+ Stock-Based Comp$6.4M
+ Deferred Tax$0
- Working Capital-$3.4M
+ Other Non-Cash$3.1M
= Operating Cash Flow-$18.5M
- Capex-$39.0K
= Free Cash Flow-$18.6M
Analysis
FY2025 free cash flow is -$18.6M. FCF conversion is 71.0% of net income. Operating cash flow was -$18.5M, with capex of -$39.0K. The largest bridge item is Stock-Based Comp at $6.4M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 4, 2026 | |
| 10-Q | Quarterly report | Nov 4, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 21, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 21, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 21, 2026 |
Does CLNN generate free cash flow?
Clene Inc. (CLNN) generated -$18.59M of free cash flow in fiscal 2025.
How much operating cash flow does CLNN produce?
Operating cash flow was -$18.55M, before capital expenditures of $39,000.00.
Continue the stock analysis
Jump to another research area for this company.